Android app Apple app link

Oaktree Acquisition Corp. III Life Sciences (OACC) Financials

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$10.35

south_east
-$0.04 (-0.39%)
Day's range
$10.35
Day's range
$10.44
$3000$3000$2500$2500$2000$2000$1500$1500$1000$1000$500$500$0$0Earning202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

OACC Income statement / Annual

Last year (2024), Oaktree Acquisition Corp. III Life Sciences's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Oaktree Acquisition Corp. III Life Sciences's net income was $2,663.41. See Oaktree Acquisition Corp. III Life Sciences,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024
Period Ended 12/31/2024
Operating Revenue $0.00
Cost of Revenue $0.00
Gross Profit $0.00
Gross Profit Ratio 0
Research and Development Expenses $0.00
General & Administrative Expenses $703.61
Selling & Marketing Expenses $0.00
Selling, General & Administrative Expenses $703.61
Other Expenses $0.00
Operating Expenses $703.61
Cost And Expenses $703.61
Interest Income $0.00
Interest Expense $0.00
Depreciation & Amortization $703.61
EBITDA $0.00
EBITDA Ratio 0
Operating Income Ratio 0
Total Other Income/Expenses Net $3,367.03
Income Before Tax $2,663.41
Income Before Tax Ratio 0
Income Tax Expense $0.00
Net Income $2,663.41
Net Income Ratio 0
EPS 0
EPS Diluted 0
Weighted Average Shares Out $4,375.00
Weighted Average Shares Out Diluted $4,375.00
Link

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.